Remove 2025 Remove Immunization Remove Medical Records
article thumbnail

Preparing Students for the Technology of Tomorrow

Drug Topics

Nau, PhD, RPh, FAPhA Publication Article Drug Topics Journal Drug Topics July/August 2025 Volume 169 Issue 04 Colleges of pharmacy are retooling curricula and faculty skill sets to ensure students are prepared to use the technology of the next decade. Association of American Medical Colleges. Accessed June 1, 2025. News release.

article thumbnail

The Value of a Medically Integrated Pharmacy to Maximize Cost Avoidance and Reduce Waste of Oral Oncolytic Medications

Pharmacy Times

SHOW MORE This abstract will be presented at the Oncology Pharmacists Connect (OPC) meeting in Austin, Texas, from June 19 to 20, 2025. Proactive strategies in oncology care enhance financial sustainability and improve patient outcomes.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Psychiatric Medication Adherence in Patients Experiencing Homelessness

Pharmacy Times

Patients were excluded if they had a primary mental health diagnosis of a substance use disorder or no documented Behavioral Health Initial Assessment Form in the electronic medical record. Accessed June 2, 2025. Reliability and validity of a new Medication Adherence Rating Scale (MARS) for the psychoses. Schizophr Res.

article thumbnail

Real-World Data on Expanding Step-Up Dosing Administration of Bispecific T-Cell Engagers in the Outpatient Setting

Pharmacy Times

Image Credit: © Love Employee - stock.adobe.com Originally presented at the 2025 Pacific Coast Reproductive Society Annual Meeting in Indian Wells, California, the abstract highlights a real-world evaluation of outpatient step-up dosing (SUD) protocols for bispecific T-cell engagers (BiTEs).

article thumbnail

Tirzepatide, Hormone Therapy Combination Increases Weight Loss Among Postmenopausal Women

Drug Topics

Postmenopausal women with overweight or obesity who were treated simultaneously with tirzepatide and menopause hormone therapy experienced increased weight loss compared to women treated with tirzepatide alone, according to data presented at ENDO 2025, held July 12 to 15 in San Francisco, California. June 30, 2025. References 1.

article thumbnail

Unlocking disease treatment with large-scale research

pharmaphorum

The research programme was officially launched at the end of October 2022, and has the aim of building a resource of five million individuals’ information by 2025. It is estimated that this will reach 70% by 2035. Industry interest. This makes it difficult to diagnose MS early. Breakthroughs to come.